Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atropine and aminophylline for respiratory problems after electroconvulsive therapy
ACTRN12614000274673Phase 4Completed
- Sponsor
- achmet ali
- Start
- Jun 2011
- Modality
- Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of atropine and aminophylline in respiratory complication and anoxemia, sponsored by achmet ali. Primary endpoints: Post-ECT respiratory abnormalities and Post-ECT oxygen desaturation. Started Jun 2011; status: completed.
02
Drugs
atropineaminophylline
03
Conditions
respiratory complicationanoxemia
Beyond the preview
Go deeper on ACTRN12614000274673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000274673.